the value of mrd as a prognostic tool in myeloma
Published 2 years ago • 353 plays • Length 5:18Download video MP4
Download video MP3
Similar videos
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
4:22
prognostic value of mrd and circulating plasma cells in myeloma
-
3:27
mrd negativity using deep sequencing is a major prognostic factor in myeloma
-
2:11
mrd as a predictor of risk in myeloma
-
1:26
mrd in myeloma: the fda perspective
-
2:05
using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
-
2:17
mrd: a promising biomarker in multiple myeloma
-
1:20
mrd in myeloma
-
2:21
mezigdomide: a novel celmod showing promise in the treatment of r/r myeloma
-
5:21
shaji kumar: comparing krd with vrd in newly diagnosed myeloma
-
9:39
myeloma for beginners - treatment and treatment decisions
-
1:37
mrd in myeloma
-
1:46
the assets of mrd in myeloma
-
4:38
the potential of mrd-adapted treatment in multiple myeloma
-
6:33
mrd as a tool to discontinue therapy in mm?
-
0:48
myeloma prognosis - the emergence of mrd
-
1:27
the real world utilization of mrd in myeloma across europe
-
2:09
mrd in multiple myeloma: prognosis, a clinical trial endpoint, and guiding treatment decisions
-
1:33
the rise of mrd in multiple myeloma: could this be an answer to a cure?
-
3:15
the evolution of mrd for myeloma
-
2:44
predicting long-term outcomes in myeloma: mrd
-
1:59
methods used to assess mrd status in multiple myeloma